Glutathione depletion increases the cytotoxicity of melphalan to PC-3, an androgen-insensitive prostate cancer cell line

This publication has 38 references indexed in Scilit:

• Studies on Prostatic Cancer: I. The Effect of Castration, of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate
  Journal of Urology, 2002
• Cancer statistics, 1990
  CA: A Cancer Journal for Clinicians, 1990
• Phase II Trial of Ifosfamide in the Treatment of Metastatic Hormone-Refractory Patients with Prostatic Cancer
  Cancer Investigation, 1990
• Effect of Glutathione on DNA Repair in Cisplatin-Resistant Human Ovarian Cancer Cell Lines
  JNCI Journal of the National Cancer Institute, 1989
• Phase II Trial of Combination Chemotherapy with Fluorouracil (F), Doxorubicin (A), and Cisplatin (P) (FAP) in Hormonally Resistant Metastatic Prostatic Adenocarcinoma
  Oncology, 1989
• Hormone-refractory metastatic prostatic cancer treated with methotrexate, cyclophosphamide plus adriamycin, cis-platinum plus 5-fluorouracil plus cyclophosphamide National prostatic cancer project randomized trial
  Urology, 1988
• Evidence That Glutathione May Determine the Differential Cell-Cycle Phase Toxicity of a Platinum(IV) Antitumor Agent1
  JNCI Journal of the National Cancer Institute, 1988
• Pharmacokinetics of oral and intravenous melphalan during routine treatment of multiple myeloma
  European Journal of Cancer and Clinical Oncology, 1982
• Prostatic Carcinoma
  New England Journal of Medicine, 1979
• Pharmaco-kinetics of melphalan following oral or intravenous administration in patients with malignant disease
  Published by Elsevier ,1978